Related Articles
MDM2 oncogene as a target for cancer therapy: An antisense approach.
The administration schedule of cyclin-dependent kinase inhibitor gene therapy and etoposide chemotherapy is a major determinant of cytotoxicity.
ARRB1 enhances the chemosensitivity of lung cancer through the mediation of DNA damage response
5-FU resistance abrogates the amplified cytotoxic effects induced by inhibiting checkpoint kinaseĀ 1 in p53-mutated colon cancer cells
Targeting Ku protein for sensitizing of breast cancer cells to DNA-damage